Kevin Balthaser
Chief Financial Officer, Aclaris Therapeutics, Inc.
Companies
- Aclaris Therapeutics, Inc.Chief financial officer Jan 6, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aclaris Therapeutics, Inc. ACRS187,453 shares2$633.6K at $3.38Mar 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 1, 2026Shares withheld for tax 677 shares at $2.87 of Aclaris Therapeutics, Inc.2
- Mar 1, 2026Exercised options 2,375 shares of Aclaris Therapeutics, Inc.2
- Feb 3, 2026Shares withheld for tax 6,449 shares at $3.47 of Aclaris Therapeutics, Inc.3
- Feb 3, 2026Exercised options 22,025 shares of Aclaris Therapeutics, Inc.3
- Feb 1, 2026Shares withheld for tax 4,984 shares at $3.51 of Aclaris Therapeutics, Inc.4
- Feb 1, 2026Exercised options 14,750 shares of Aclaris Therapeutics, Inc.4
- Jan 2, 2026Shares withheld for tax 4,461 shares at $2.88 of Aclaris Therapeutics, Inc.5
- Jan 2, 2026Exercised options 13,200 shares of Aclaris Therapeutics, Inc.5
- Jan 1, 2026Shares withheld for tax 2,250 shares at $3.01 of Aclaris Therapeutics, Inc.5
- Jan 1, 2026Exercised options 7,500 shares of Aclaris Therapeutics, Inc.5
- Dec 31, 2025Shares withheld for tax 19,934 shares at $3.01 of Aclaris Therapeutics, Inc.5
- Dec 31, 2025Exercised options 73,750 shares of Aclaris Therapeutics, Inc.5
- Mar 1, 2025Shares withheld for tax 727 shares at $1.99 of Aclaris Therapeutics, Inc.6
- Mar 1, 2025Exercised options 2,375 shares of Aclaris Therapeutics, Inc.6
- Mar 1, 2025Exercised options 1,100 shares of Aclaris Therapeutics, Inc.6
- Feb 1, 2025Shares withheld for tax 5,816 shares at $2.48 of Aclaris Therapeutics, Inc.7
- Feb 1, 2025Exercised options 14,750 shares of Aclaris Therapeutics, Inc.7
- Jan 2, 2025Shares withheld for tax 5,059 shares at $2.48 of Aclaris Therapeutics, Inc.8
- Jan 2, 2025Exercised options 13,200 shares of Aclaris Therapeutics, Inc.8
- Jan 1, 2025Shares withheld for tax 2,430 shares at $2.48 of Aclaris Therapeutics, Inc.8
- Jan 1, 2025Exercised options 7,500 shares of Aclaris Therapeutics, Inc.8
- Dec 31, 2024Shares withheld for tax 30,732 shares at $2.48 of Aclaris Therapeutics, Inc.8
- Dec 31, 2024Exercised options 73,750 shares of Aclaris Therapeutics, Inc.8
- Sep 1, 2024Shares withheld for tax 286 shares at $1.18 of Aclaris Therapeutics, Inc.9
- Sep 1, 2024Exercised options 1,000 shares of Aclaris Therapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 5, 2026
- 4SEC EDGARForm 4 filed Feb 3, 2026
- 5SEC EDGARForm 4 filed Jan 5, 2026
- 6SEC EDGARForm 4 filed Mar 4, 2025
- 7SEC EDGARForm 4 filed Feb 4, 2025
- 8SEC EDGARForm 4 filed Jan 3, 2025
- 9SEC EDGARForm 4 filed Sep 4, 2024